Diagnostic clue of nodular fasciitis mimicking metastasis in papillary thyroid cancer, mismatching findings on 18F-FDG PET/CT and 123I whole body scan: A case report

被引:5
|
作者
Seo, Minjung [1 ]
Kim, Misung [2 ]
Kim, Eun Sook [3 ]
Sim, Hongbo [4 ]
Jun, Sungmin [5 ]
Park, Seol Hoon [1 ]
机构
[1] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Nucl Med, 877 Bangeojinsunhwando, Ulsan 44033, South Korea
[2] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Pathol, Ulsan 44033, South Korea
[3] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 44033, South Korea
[4] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Neurosurg, Ulsan 44033, South Korea
[5] Kosin Univ, Gospel Hosp, Coll Med, Dept Nucl Med, Busan 49267, South Korea
关键词
nodular fasciitis; thyroid cancer; radioactive iodine; fluorodeoxyglucose; positron emission tomography; whole body scan; SOFT-TISSUE METASTASES; DISTANT METASTASES; FDG PET; FLUORODEOXYGLUCOSE UPTAKE; IMAGING FEATURES; CARCINOMA; BENIGN; TUMORS; SUV;
D O I
10.3892/ol.2017.6181
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study reports a case of nodular fasciitis incidentally detected in a patient with papillary thyroid cancer. A 47-year-old woman underwent a total thyroidectomy and radioactive iodine therapy for papillary thyroid cancer. On a follow-up fluorodeoxyglucose (F-18-FDG) PET/computed tomography (CT) scan after 12 months, a focal F-18-FDG-avid lesion was incidentally detected in the paraspinal muscle. It was well-enhanced on CT and magnetic resonance imaging, indicating metastasis. However, the lesion was not iodine avid on the I-123 whole body scan, which favored benign etiology over metastasis from thyroid cancer. For pathological confirmation, surgical excision was performed and the paraspinal lesion was finally confirmed as nodular fasciitis. Therefore, it was suggested that nodular fasciitis may be included in the differential diagnosis of a F-18-FDG avid/iodine non-avid soft tissue lesion in patients with thyroid cancer. In such circumstances, I-123 whole body scans may serve a role in non-invasive work-up, and prevent unnecessary surgical procedures.
引用
收藏
页码:1167 / 1171
页数:5
相关论文
共 41 条
  • [21] Diagnostic Performance of CT Attenuation Values of Focal 18F-FDG Avid Breast Lesions Detected on Whole-Body PET-CT in Postoperative Breast Cancer Patients
    Plaza, Michael J.
    Collado-Mesa, Fernando
    Bokhoor, Justin
    Alperin, Noam
    Yepes, Monica M.
    BREAST JOURNAL, 2014, 20 (03) : 235 - 242
  • [22] Diagnostic Performance of 18F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative 131I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb Level
    Qiu, Zhong-Ling
    Wei, Wei-Jun
    Shen, Chen-Tian
    Song, Hong-Jun
    Zhang, Xin-Yun
    Sun, Zhen-Kui
    Luo, Quan-Yong
    SCIENTIFIC REPORTS, 2017, 7
  • [23] Whole-Body Metabolic Tumor Volume, as Determined by 18F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis
    Son, Seung Hyun
    Lee, Sang-Woo
    Jeong, Shin Young
    Song, Bong-Il
    Chae, Yee Soo
    Ahn, Byeong-Cheol
    Lee, Jaetae
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (04) : 878 - 885
  • [24] Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Bannas, Peter
    Derlin, Thorsten
    Groth, Michael
    Apostolova, Ivayla
    Adam, Gerhard
    Mester, Janos
    Klutmann, Susanne
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (01) : 77 - 85
  • [25] Could [18]F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive 131I whole body scan?
    Piccardo, A.
    Foppiani, L.
    Morbelli, S.
    Bianchi, P.
    Barbera, F.
    Biscaldi, E.
    Altrinetti, V.
    Villavecchia, G.
    Cabria, M.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 55 (01) : 57 - 65
  • [26] F-18 FDG PET/CT imaging in the diagnostic work-up of thyroid cancer patients with high serum thyroglobulin, negative I-131 whole body scan and suppressed thyrotropin: 8-year' experience
    Elboga, U.
    Karaoglan, H.
    Sahin, E.
    Kalender, E.
    Demir, H. D.
    Basibuyuk, M.
    Celen, Y. Zeki
    Yilmaz, M.
    Ozkaya, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (03) : 396 - 401
  • [27] Detection of Subcentimeter Metastatic Cervical Lymph Node by 18F-FDG PET/CT in Patients With Well-Differentiated Thyroid Carcinoma and High Serum Thyroglobulin But Negative 131I Whole-Body Scan
    Kunawudhi, Anchisa
    Pak-art, Rattaplee
    Keelawat, Somboon
    Tepmongkol, Supatporn
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : 561 - 567
  • [28] 18F-FDG PET/CT, 123I-MIBG and 99mTc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma
    Skoura, Evangelia
    Oikonomopoulos, Georgios
    Vasileiou, Spyridon
    Kyprianou, Diogenis
    Koumakis, Georgios
    Datseris, Ioannis E.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2014, 17 (01): : 58 - 61
  • [29] Impact of TSH stimulation on 2-[18F]FDG PET/CT results in patients with papillary thyroid carcinoma presented with elevated serum thyroglobulin level and negative diagnostic iodine-131 whole-body scan
    Emami-Ardekani, Alireza
    Ghorbani-Nik, Fariba
    Karamzade-Ziarati, Najme
    Manafi-Farid, Reyhaneh
    Fard-Esfahani, Armaghan
    Fallahi, Babak
    Beiki, Davood
    Salehi, Yalda
    Eftekhari, Mohammad
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2022, 30 (02): : 88 - 95
  • [30] Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Peter Bannas
    Thorsten Derlin
    Michael Groth
    Ivayla Apostolova
    Gerhard Adam
    Janos Mester
    Susanne Klutmann
    Annals of Nuclear Medicine, 2012, 26 : 77 - 85